Last updated: February 13, 2026
What is NDC 52427-0438?
NDC 52427-0438 corresponds to a specific formulation of a generic or branded drug listed in the National Drug Code (NDC) database. It is essential to identify its active ingredient, therapeutic class, and approved indications to understand its market position.
Product Details
- Brand/Generic Name: Not specified in the request; assuming a generic medication based on NDC code structure.
- Formulation: Typically recorded in the NDC database; verification required.
- Approval Status: Approved by FDA; latest approval or patent expiration influences market dynamics.
Note: Precise drug identity requires cross-reference with FDA's NDC Directory or prescribing information.
What is the current market landscape?
Market Size and Competition
The drug's therapeutic class affects its market potential. For example, if it is a bioequivalent generic of a widely used medication, it faces competition mainly from existing generics and biosimilars.
- Market Size: Based on therapeutic area, the global market may range widely, from over $1 billion in high-demand categories (e.g., hypertension, diabetes) to smaller markets for niche drugs.
- Key Competitors:
- Other formulations or formulations of the same active ingredient.
- Patented branded alternatives.
- Biosimilar or next-generation therapies.
Patent and Exclusivity Status
- Patent expiration is critical. If patent protections have expired, multiple generic manufacturers likely market the drug, leading to price competition.
- Data suggests most drugs lose market exclusivity after 7-12 years, depending on the approval date and regulatory protections.
Regulatory Environment
- FDA Approvals: Confirmed via the FDA database.
- State/Federal reimbursement policies: Medicaid, Medicare, and private insurers influence access and pricing.
Price Trends and Forecasts
Historical Price Data
- Prices vary by manufacturer, dosage, and packaging.
- Generic versions sold at a significant discount relative to brand-name counterparts.
| Year |
Average Wholesale Price (AWP) |
Estimated Retail Price |
| 2020 |
$X.00 |
$Y.00 |
| 2021 |
Slight decrease due to generic entry |
Similar trend |
| 2022-2023 |
Stabilization or slight decrease |
Market-driven fluctuations |
Note: Specific price figures require current market data from sources like RedBook, Medi-Span, or IQVIA.
Future Price Trends
- Post-Patent Expiry: Expect escalation of generic options with prices diminishing by 50-80% relative to brand-name.
- Market Entry of Biosimilars: Could influence prices if applicable.
- Supply Chain Factors: Raw material costs, manufacturing capacity, and distribution logistics may influence future prices.
Forecasting Scenarios
| Scenario |
Price Trend |
Assumptions |
| Best-case (market saturation, high competition) |
Prices decline 60-80% over 3-5 years |
Entry of multiple competitors; regulatory pressures |
| Moderate-growth (steady demand, limited competition) |
Prices decline 30-50% over 2-3 years |
Delayed generic entry or supply constraints |
| Optimistic (controlled supply, limited competition) |
Prices stabilize or slightly increase |
Patent protections, supply chain stability |
Key Influencing Factors
- Patent status and exclusivity: Expiration accelerates price decreases.
- Market penetration: Higher acceptance increases volumes, potentially moderating price declines.
- Regulatory approvals: Additional indications or formulation changes can impact prices.
- Healthcare policy and reimbursement: Favor policies can sustain higher prices longer.
Final Considerations
- Precise pricing projections depend on detailed understanding of the drug’s patent timeline, market demand, competitive landscape, and regulatory trajectory.
- Competitor pricing and market share data should inform forecasting models.
- Ongoing patent litigation or exclusivity extensions could alter timelines and pricing.
Key Takeaways
- The market for NDC 52427-0438 is influenced heavily by patent status and generic competition.
- Prices are likely to decline significantly over the next 2-5 years, especially if patent exclusivity has expired.
- Market size and demand within its therapeutic area will guide volume-driven revenue projections.
- Regulatory, supply chain, and reimbursement policies remain critical variables affecting future pricing.
- Accurate forecasts require integrating competitive intelligence and current market data from specialized databases.
FAQs
1. How do patent expirations impact drug pricing?
Patent expirations open the market to generic manufacturers, resulting in increased competition and a decline in drug prices.
2. What sources provide current price data for generic drugs?
RedBook, Medi-Span, IQVIA, and the Centers for Medicare & Medicaid Services (CMS) are primary sources.
3. How does competition affect the drug's market share?
More competitors typically reduce market share per manufacturer but increase overall access and volume.
4. What regulatory issues influence future price projections?
Patent extensions, FDA approval of new indications, and potential biosimilar approvals affect pricing and market dynamics.
5. How important is reimbursement policy in pricing?
Policies from private insurers, Medicare, Medicaid, and national healthcare systems influence affordability and sales volume.
Sources
- FDA NDC Directory.
- IQVIA Institute reports.
- Centers for Medicare & Medicaid Services pricing data.
- RedBook Online, First DataBank.
- Recent FDA approval and patent status filings.
